Evidence map›Paper›PMID 38864855›Full record

ArticleZeitschrift fur Rheumatologie2024

[Idiopathic inflammatory myopathies : An interdisciplinary challenge].

Dana Lemmer, Tobias Ruck, Anne Schänzer, Konstantinos Triantafyllias, Rachel Zeng, Rebecca Hasseli-Fräbel

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dana LemmerAbteilung für Rheumatologie, Klinische Immunologie und Osteologie, Immanuel Krankenhaus Berlin, Berlin, Deutschland.
Tobias RuckKlinik für Neurologie, Medizinische Fakultät und Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
Anne SchänzerInstitut für Neuropathologie, Justus-Liebig-Universität Gießen, Gießen, Deutschland.
Konstantinos TriantafylliasRheumazentrum Rheinland-Pfalz, Bad Kreuznach, Deutschland.
Rachel ZengKlinik für Neurologie, Universitätsmedizin Göttingen, Göttingen, Deutschland.
Rebecca Hasseli-FräbelMedizinische Klinik D, Sektion für Rheumatologie und Klinische Immunologie, Abteilung für Translationale Rheumatologie und Immunologie, Institut für Muskuloskelettale Medizin (IMM), Universitätsklinikum Münster, Münster, Deutschland. hasseli@rheumathek.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic inflammatory myopathies (IIM) are rare diseases (incidence 1:100,000) with a wide range of clinical symptoms and manifestations. Typical indicators of IIM are proximally emphasized muscle weakness and myalgias, which are usually accompanied by elevated creatine kinase levels and muscle atrophy. The autoantibody diagnostics separate IIM into different entities, which are each associated with a typical risk of organ manifestations and the occurrence of tumors. The IIM represents an interdisciplinary challenge and the diagnostics and treatment require the involvement of several disciplines including rheumatology, neurology, neuropathology, dermatology and pneumology. An accurate diagnosis and careful tumor screening are essential because of the association between certain subgroups of IIM and the occurrence of malignant tumors.

Indexed as

MyositisDiagnosis, DifferentialEvidence-Based MedicineHumansPatient Care TeamRheumatologyDermatomyositisInterstitial lung diseasesMyositis-associated antibodiesMyositis syndromesPolymyositis

Identifiers

PMID38864855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.